| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |